Quantum Cyber N.V.
QUCY · XNASCIK 1874252fmd_10PXFBX4MS9B37R42HQ2A2T59AManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 21 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | (0) | 0 | 0 | 0 | 1 | 1 | 0 |
| Research and development | 0 | 0 | 0 | 5 | 10 | 6 | 5 |
| Selling, general and administrative | 1 | 0 | 8 | 15 | 11 | 13 | 9 |
| Total operating expenses | – | – | – | – | – | 19 | 17 |
| Operating income | (1) | (1) | (10) | (26) | (27) | (19) | (16) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Other non-operating income (expense) | – | – | – | – | – | (3) | (0) |
| Income before taxes | (1) | (1) | (12) | (26) | (26) | (22) | (16) |
| Net income from continuing operations | (1) | 1 | 12 | 26 | 26 | 22 | – |
| Net income | (1) | (1) | (12) | (26) | (26) | (22) | (16) |